Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Mental Health

Large-scale review reveals untapped potential of blood pressure medications in migraine prevention

by Eric W. Dolan
July 26, 2023
in Mental Health
Share on TwitterShare on Facebook
Stay on top of the latest psychology findings: Subscribe now!

In an large-scale review recently published in Cephalalgia, researchers found that a broader range of blood pressure (BP) medications could be leveraged more efficiently than currently practiced to prevent migraines. The study underlines the untapped potential of these common and cost-effective drugs in migraine prevention, a condition affecting up to 1 billion people worldwide.

Migraine has a global prevalence of approximately 14-15% of the population. While BP-lowering medications, such as beta-blockers and angiotensin II receptor blockers (ARBs), are suggested by guidelines for migraine prevention, the available literature is scarce regarding the efficiency of all classes of BP-lowering medications or combination agents in preventing migraines.

This study sought to evaluate the effect of various classes of antihypertensive medications, including alpha-blockers, ARB, angiotensin-converting enzyme inhibitors, beta-blockers, and calcium channel blockers on episodic migraine prevention.

“One in every seven people experiences migraine,” said study author Faraidoon Haghdoost, a research fellow in headache disorders at The George Institute for Global Health at the University of New South Wales.

“It is the leading cause of disability in females aged under 50 and second in all ages and genders. We need more treatment options for the management of migraine. While some blood pressure lowering medications are already included in treatment guidelines for migraine prevention, what about the rest of these medications? Are they effective too? I‘m interested in finding answers to these questions.”

The researchers conducted a systematic review and meta-analysis involving more than 4,300 individuals from 50 scientific trials. Given that prior studies might have had small sample sizes, variable methodologies, or focused on specific drugs within these classes, a meta-analysis allowed them to pool data from diverse studies, improve statistical power, resolve potential discrepancies, and provide a more comprehensive and generalizable understanding of the topic.

The majority of the trials included in the meta-analysis (70%) had a cross-over design, and the overall mean age of participants was 39, with a significant female representation (79%). The study examined a broad array of BP-lowering medications, with a variety of different drugs represented within each class.

The researchers found that, on average, BP-lowering medications could reduce the number of headache days experienced per month by approximately one day, in addition to the average placebo effect.

The research revealed that almost all classes of antihypertensive medications demonstrated some degree of efficacy in reducing headache frequency in people with migraine. This result was statistically significant for all classes and separately significant for several specific drugs within the classes, including clonidine, candesartan, atenolol, bisoprolol, propranolol, timolol, nicardipine, and verapamil.

“Almost all classes of blood pressure lowering medications are useful for the prevention and management of migraine,” Haghdoost told PsyPost. “These medications are globally available, affordable and have few side effects.”

The study’s inclusivity marks a significant contribution to the understanding of the effects of BP-lowering medications in managing episodic migraines. Nonetheless, the researchers highlighted several limitations, including a small sample size for all classes except BBs and the age of many of the studies, which didn’t adhere to current guidelines. Other concerns included inconsistent definitions of outcomes and differences in reported endpoints across studies.

“Our study is a review of previous published papers on the topic. We found that most of the studies assessing the effect of blood pressure lowering medications on migraine are old with very small sample sizes. We need more studies with larger sample sizes that are based on currently accepted methods of evaluating migraine medications,” Haghdoost said.

“We are working on more studies to understand the potential mechanisms for the effect of blood pressure lowering medications on migraine and headache. We would like to know if reducing blood pressure is the reason for this effect.”

Despite these limitations, the study provides valuable insights into the possible role of BP-lowering medications in preventing migraines, at least in episodic migraine patients.

Cheryl Carcel, the study’s Joint Principal Investigator, emphasized the practical implications of the study, especially for countries where newer migraine medications might be expensive, restricted, or unavailable. The research suggests that common BP medications, which general practitioners are comfortable prescribing, could serve as an important preventive measure for patients with migraines or severe headache episodes.

The study, “The effect of blood pressure lowering medications on the prevention of episodic migraine: A systematic review and meta-analysis“, was authored by Cheryl Carcel, Faraidoon Haghdoost, Joanne Shen, Puneet Nanda, Yu Bai, Emily Atkins, Takako Torii-Yoshimura, Alexander J. Clough, Leo Davies, Dennis Cordato, Lyn R. Griffiths, Grace Balicki, Xia Wang, Kota Vidyasagar, Alejandra Malavera, Craig S. Anderson, Alessandro S. Zagami, Candice Delcourt, and Anthony Rodgers.

TweetSendScanShareSendPinShareShareShareShareShare

RELATED

Sex differences in brain structure are present at birth and remain stable during early development
Alzheimer's Disease

Key Alzheimer’s protein found at astonishingly high levels in healthy newborns

July 18, 2025

What if a protein we thought caused dementia is actually essential for building a healthy brain? New research shows a key Alzheimer's protein is abundant in newborns, flipping our understanding of the disease and its biological triggers on its head.

Read moreDetails
Bacteria in water, 3d illustration
Anxiety

Common antidepressants and anti-anxiety drugs tied to major shifts in gut microbiome composition

July 18, 2025

A surprising new study reveals a twist in the gut-brain connection. While anxiety and depression are linked to distinct gut bacteria, commonly prescribed medications show an even stronger association with microbiome changes than the mental health conditions themselves.

Read moreDetails
New study links honor cultures to higher rates of depression, suicidal thoughts
Depression

A single dose of lamotrigine causes subtle changes in emotional memory

July 17, 2025

A new study suggests that lamotrigine, a drug used to prevent bipolar depression, may influence how people recall emotional information. Healthy volunteers who took a single dose remembered more positive self-relevant words than negative ones, without reporting mood changes.

Read moreDetails
Autism severity rooted in embryonic brain growth, study suggests
Cognitive Science

Common pollutant in drinking water linked to brain damage and cognitive impairment

July 17, 2025

New research in mice reveals that prolonged exposure to "forever chemicals," or PFAS, can disrupt brain function and impair memory, even at low concentrations. The findings add to growing evidence that these common chemicals may pose significant risks to brain health.

Read moreDetails
New study links honor cultures to higher rates of depression, suicidal thoughts
Depression

New study links honor cultures to higher rates of depression, suicidal thoughts

July 17, 2025

A new study reveals a stark link between culture and mental health. People living in U.S. states with strong "honor cultures" are more likely to experience depression and suicidal thoughts, with the connection being particularly strong for non-Hispanic White residents.

Read moreDetails
Loneliness is associated with a 31% higher risk of developing dementia, finds largest study to date
Alzheimer's Disease

Persistent apathy predicts faster functional decline in Alzheimer’s disease

July 17, 2025

In a large longitudinal study, researchers identified apathy as the most consistent predictor of functional decline in people with Alzheimer’s disease, suggesting that this often-overlooked symptom may play a more central role in disease progression than previously recognized.

Read moreDetails
Yoga nidra meditation reduces stress and reshapes cortisol rhythms, study finds
Meditation

Yoga nidra meditation reduces stress and reshapes cortisol rhythms, study finds

July 17, 2025

Can meditation change your biology? A new study suggests so. Researchers found that practicing yoga nidra not only reduces stress and improves mood but also alters the daily rhythm of the stress hormone cortisol, highlighting a powerful mind-body connection.

Read moreDetails
New research sheds light on psychedelics’ complex relationship to psychosis and mania
Mental Health

Psychedelic retreats show promise in easing depression, PTSD, and reintegration struggles among veterans

July 16, 2025

Military veterans who attended psilocybin or ayahuasca retreats showed improvements in measures of depression, PTSD, anxiety, and reintegration into civilian life compared to their baseline assessments.

Read moreDetails

SUBSCRIBE

Go Ad-Free! Click here to subscribe to PsyPost and support independent science journalism!

STAY CONNECTED

LATEST

Key Alzheimer’s protein found at astonishingly high levels in healthy newborns

People’s ideal leader isn’t hyper-masculine — new study shows preference for androgynous traits

Chronic pain rewires how the brain processes punishment, new research suggests

Common antidepressants and anti-anxiety drugs tied to major shifts in gut microbiome composition

New psychology study: Inner reasons for seeking romance are a top predictor of finding it

Scientists demonstrate that “AI’s superhuman persuasiveness is already a reality”

Cannabis alternative 9(R)-HHC may be as potent as THC, study in mice suggests

A single dose of lamotrigine causes subtle changes in emotional memory

         
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy